Magnesium Sulfate Ariti

Magnesium sulfate, the active ingredient in Magnesium Sulfate Ariti, is a mineral supplement presented as an injection for intravenous use. It treats magnesium deficiency and is employed in obstetric, cardiac and respiratory emergencies.

GNH USA supplies Magnesium Sulfate Ariti as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Magnesium sulfate is used to correct electrolyte disturbances and to manage several acute clinical conditions.

- Magnesium deficiency: restores normal serum magnesium levels. - Eclampsia and severe pre‑eclampsia: prevents and treats seizures in pregnant women. - Torsades de pointes and other cardiac arrhythmias: stabilises cardiac electrical activity. - Severe asthma exacerbations: acts as an adjunct to improve bronchodilation. - Neuroprotection in obstetric and surgical settings: reduces neuronal injury during ischemic events.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Flushing or warmth at the infusion site - Nausea or vomiting - Headache - Hypotension - Sweating - Dizziness

Serious or Rare Side Effects: - Respiratory depression - Severe hypotension or cardiovascular collapse - Hypermagnesemia leading to cardiac arrest - Arrhythmias - Allergic or anaphylactoid reactions - Neuromuscular blockade causing muscle weakness

Magnesium sulfate requires careful monitoring and specific safety measures.

- Assess baseline serum magnesium: obtain laboratory values before initiating infusion. - Monitor cardiac rhythm: continuous ECG monitoring during administration. - Adjust dose in renal impairment: reduce infusion rate or total dose. - Avoid rapid bolus in neuromuscular disease: give slow infusion to prevent blockade. - Use with caution in pregnancy: category unknown, weigh maternal benefits against potential fetal risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesium sulfate can interact with several drug classes, necessitating vigilance.

Major Interactions (Avoid): - Calcium‑containing solutions: risk of precipitation and reduced efficacy. - Neuromuscular blocking agents: potentiation of muscle relaxation. - Aminoglycoside antibiotics: increased neurotoxicity.

Moderate Interactions (Monitor Closely): - Vasodilators: additive hypotensive effect. - Beta‑blockers: enhanced bradycardia. - Loop diuretics: may increase magnesium loss and alter serum levels.